Mediphar Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.20 M
- Revenue Growth 17.64%
- Profit Growth 145.43%
- Ebitda 64.16%
- Net Worth 12.58%
- Total Assets 13.09%
About Mediphar Lifesciences
Mediphar Lifesciences Private Limited (MLPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2018 (Six years and four months 26 days old ). Its registered office is in Chandigarh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.20 M.
Poonam Gupta and Vinay Kumar serve as directors at the Company.
Company Details
-
Location
Chandigarh, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U24100CH2018PTC042166
-
Company No.
042166
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Sep 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
What products or services does Mediphar Lifesciences Private Limited offer?
Mediphar Lifesciences Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antibiotic Injection, Ayurvedic,Herbal Products & Medicine, Ayurvedic Herbal Syrups & Tonics, Pharma Franchise, Allopathic PCD Pharma Franchise, PCD Pharma Franchise, Vitamin & Multivitamin Injections, Methylcobalamin Injection.
Who are the key members and board of directors at Mediphar Lifesciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Gupta
|
Director | 20-Sep-2018 | Current |
|
Vinay Kumar
|
Director | 20-Sep-2018 | Current |
Financial Performance of Mediphar Lifesciences.
Mediphar Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.64% increase. The company also saw a substantial improvement in profitability, with a 145.43% increase in profit. The company's net worth Soared by an impressive increase of 12.58%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Mediphar Lifesciences?
Unlock access to Mediphar Lifesciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹1.20 M
₹0
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 0.12 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2023 | Hdfc Bank Limited | ₹1.20 M | Open |
How Many Employees Work at Mediphar Lifesciences?
Unlock and access historical data on people associated with Mediphar Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediphar Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediphar Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.